LOUISVILLE — After selling to California-based NantCell Inc., GlobeImmune is restarting operations at its Louisville facility.
Real estate is where life happens. The places where we spend our time should enrich our lives by giving us a sense of community and… read more
The company will be manufacturing at its Louisville facility to support clinical trials for products targeting certain cancers and tumors.
NantCell purchased a controlling interest of GlobeImmune in March for more than $2 million.